SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
________________________
 
FORM 8-K
 

 
Current Report
 

 
Pursuant to Section 13 or 15(d) of the Securities
 
Exchange Act of 1934
 
July 15, 2010
 
Date of Report (Date of earliest event reported)
 
THE GREAT ATLANTIC & PACIFIC TEA COMPANY, INC.
 
(Exact name of registrant as specified in its charter)
 
Maryland
1-4141
13-1890974
(State or other jurisdiction of
incorporation or organization)
(Commission file number)
(I.R.S. Employer
Identification No.)

Two Paragon Drive
 
Montvale, New Jersey 07645
 
(Address of principal executive offices)
 
(201) 573-9700
 
(Registrant’s telephone number, including area code)
 
Not Applicable
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[   ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[   ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[   ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[   ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


 
 

 

Item 5.07. Submission of Matters to a Vote of Security Holders.

The Great Atlantic & Pacific Tea Company, Inc. (the “Company”) held its Annual Meeting of Stockholders (the “Annual Meeting”) on July 15, 2010 at which the Company’s stockholders approved (a) an amendment to the Company’s charter to increase the total number of shares of common stock which the Company has authority to issue from 160,000,000 to 260,000,000 shares (“Proposal 1”), (b) the reelection of the following persons to the Company’s Board of Directors (i) Bobbie Andrea Gaunt, Dan Plato Kourkoumelis, Edward Lewis, Gregory Mays and Maureen B. Tart-Bezer, by an affirmative vote of a plurality of all the voting securities of the Company cast, (ii) John D. Barline, Dr. Jens-Jurgen Bockel, Dr. Andreas Guldin and Christian W. E. Haub, by a majority vote of the shares of the Company’s Series A-T Preferred Stock present at the Annual Meeting and (iii) Frederic F. Brace and Terrence J. Wallock, by a majority vote of the shares of the Company’s Series A-Y Preferred Stock present at the Annual Meeting (clauses (i), (ii) and (iii) collectively, “Proposal 2”) and (c) the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm (“Proposal 3”).

Description of Matters Submitted

 
 
For
 
Against
 
Abstentions
Broker
Non-Votes
Proposal 1 - Charter Amendment
 
71,233,744
 
4,430,086
 
10,559
 
5,987,608
         



 
For
Withheld
Broker
Non-Votes
Proposal 2 - Election of Directors
     
By holders of all voting securities:
     
   Bobbie Andrea Gaunt
67,718,119
7,956,271
5,997,606
   Dan Plato Kourkoumelis
75,290,732
383,658
5,997,606
   Edward Lewis
75,291,335
383,055
5,997,606
   Gregory Mays
67,289,071
8,375,319
5,997,606
   Maureen B. Tart-Bezer
75,289,814
384,576
5,997,606
By holders of Series A-T Preferred Stock:
     
   John D. Barline
12,000,000
0
N/A
   Dr. Jens-Jurgen Bockel
12,000,000
0
N/A
   Dr. Andreas Guldin
12,000,000
0
N/A
  Christian W. E. Haub
12,000,000
0
N/A
By holders of Series A-Y Preferred Stock:
     
   Frederic F. Brace
23,000,000
0
N/A
   Terrence J. Wallock
23,000,000
0
N/A

 
 
For
 
Against
 
Abstentions
Broker
Non-Votes
Proposal 3 - Appointment of PricewaterhouseCoopers LLP
 
 
81,440,568
 
 
211,551
 
 
19,551
 
 
0
         



 
 

 

SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
Dated:  July 20, 2010
 
THE GREAT ATLANTIC & PACIFIC TEA
 
COMPANY, INC.
 
By:         /s/ Christopher W. McGarry                                                                  
Name: Christopher W. McGarry
Title:   Senior Vice President and General Counsel